Publicaciones en las que colabora con FRANCISCO JAVIER DOLCET ROCA (51)

2024

  1. Sprouty1 is a broad mediator of cellular senescence

    Cell Death and Disease, Vol. 15, Núm. 4

2023

  1. In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53-Deficient Endometrial Cancers

    Advanced Science, Vol. 10, Núm. 32

  2. Metformin exhibits antineoplastic effects on Pten-deficient endometrial cancer by interfering with TGF-β and p38/ERK MAPK signalling

    Biomedicine and Pharmacotherapy, Vol. 168

  3. Transient and DNA-free in vivo CRISPR/Cas9 genome editing for flexible modeling of endometrial carcinogenesis

    Cancer Communications

2022

  1. A dominant negative mutation uncovers cooperative control of caudal Wolffian duct development by Sprouty genes

    Cellular and Molecular Life Sciences, Vol. 79, Núm. 10

  2. Lack of extracellular matrix switches TGF-β induced apoptosis of endometrial cells to epithelial to mesenchymal transition

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Endometrial pten deficiency leads to smad2/3 nuclear translocation

    Cancers, Vol. 13, Núm. 19

2020

  1. T-Type Calcium Channels as Potential Therapeutic Targets in Vemurafenib-Resistant BRAFV600E Melanoma

    Journal of Investigative Dermatology, Vol. 140, Núm. 6, pp. 1253-1265

2019

  1. Tumor suppressive function of E2F-1 on PTEN-induced serrated colorectal carcinogenesis

    Journal of Pathology, Vol. 247, Núm. 1, pp. 72-85

2017

  1. A Smad3-PTEN regulatory loop controls proliferation and apoptotic responses to TGF-β in mouse endometrium

    Cell Death and Differentiation, Vol. 24, Núm. 8, pp. 1443-1458

  2. Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer

    Autophagy, Vol. 13, Núm. 3, pp. 608-624

  3. Endometrial carcinoma: Specific targeted pathways

    Advances in Experimental Medicine and Biology (Springer New York LLC), pp. 149-207

  4. Palbociclib has antitumour effects on Pten-deficient endometrial neoplasias

    Journal of Pathology, Vol. 242, Núm. 2, pp. 152-164

2016

  1. 2-phenylethynesulphonamide (PFT-μ) enhances the anticancer effect of the novel hsp90 inhibitor NVP-AUY922 in melanoma, by reducing GSH levels

    Pigment Cell and Melanoma Research, Vol. 29, Núm. 3, pp. 352-371

  2. Bioluminescence Imaging to Monitor the Effects of the Hsp90 Inhibitor NVP-AUY922 on NF-κB Pathway in Endometrial Cancer

    Molecular Imaging and Biology, Vol. 18, Núm. 4, pp. 545-556

  3. Oral intake of genetically engineered high-carotenoid corn ameliorates hepatomegaly and hepatic steatosis in PTEN haploinsufficient mice

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1862, Núm. 4, pp. 526-535

2015

  1. Impaired Vitamin D signaling in endothelial cell leads to an enhanced leukocyte-endothelium interplay: Implications for atherosclerosis development

    PLoS ONE, Vol. 10, Núm. 8

2014

  1. Antioxidants impair anti-tumoral effects of Vorinostat, but not anti-neoplastic effects of Vorinostat and caspase-8 downregulation

    PLoS ONE, Vol. 9, Núm. 3

2013

  1. Combination of Vorinostat and caspase-8 inhibition exhibits high anti-tumoral activity on endometrial cancer cells

    Molecular Oncology, Vol. 7, Núm. 4, pp. 763-775

  2. Endometrial carcinoma: Molecular alterations involved in tumor development and progression

    Oncogene, Vol. 32, Núm. 4, pp. 403-413